Grand rounds at the National Institutes of Health: HDAC inhibitors as radiation modifiers, from bench to clinic

por Shabason, Jacob E, Tofilon, Philip J, Camphausen, Kevin
Publicado 2011

Phase I and phase II clinical trials in sarcoma: Implications for drug discovery and development

por Lee, Daniel Y., Staddon, Arthur P., Shabason, Jacob E., Sebro, Ronnie
Publicado 2019

Radiation Therapy in Metastatic Soft Tissue Sarcoma: From Palliation to Ablation

por Shah, Nishant K., Yegya-Raman, Nikhil, Jones, Joshua A., Shabason, Jacob E.
Publicado 2021

Evaluating Thresholds to Adopt Hypofractionated Preoperative Radiotherapy as Standard of Care in Sarcoma

por Valle, Luca F., Bernthal, Nicholas, Eilber, Fritz C., Shabason, Jacob E., Bedi, Meena, Kalbasi, Anusha
Publicado 2021

Predictors of Wound Complications following Radiation and Surgical Resection of Soft Tissue Sarcomas

por LeBrun, Drake G., Guttmann, David M., Shabason, Jacob E., Levin, William P., Kovach, Stephen J., Weber, Kristy L.
Publicado 2017

Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma

por Jain, Varsha, Venigalla, Sriram, Sebro, Ronnie A., Karakousis, Giorgos C., Wilson, Robert J., Weber, Kristy L., Shabason, Jacob E.
Publicado 2019

Adult Pleomorphic Rhabdomyosarcomas: Assessing Outcomes Associated with Radiotherapy and Chemotherapy Use in the National Cancer Database

por Reddy, Vishruth K., Jain, Varsha, Wilson II, Robert J., Hartner, Lee P., Diamond, Mark, Sebro, Ronnie A., Weber, Kristy L., Maki, Robert G., Shabason, Jacob E.
Publicado 2021

Definitive Local Therapy Is Associated with Improved Survival in Metastatic Soft Tissue Sarcomas

por Reddy, Vishruth K., Jain, Varsha, Venigalla, Sriram, Nimgaokar, Vivek, Amurthur, Ashwin, Lee, Daniel Y., Sebro, Ronnie A., Maki, Robert G., Wilson, Robert J., Weber, Kristy L., Shabason, Jacob E.
Publicado 2021

Chemotherapy and Survival in Patients with Primary High-Grade Extremity and Trunk Soft Tissue Sarcoma

por Graham, Danielle S., van Dams, Ritchell, Jackson, Nicholas J., Onyshchenko, Mykola, Eckardt, Mark A., DiPardo, Benjamin J., Nelson, Scott D., Chmielowski, Bartosz, Shabason, Jacob E., Singh, Arun S., Eilber, Fritz C., Kalbasi, Anusha
Publicado 2020

Concurrent Nab-paclitaxel and Radiotherapy: Novel Radiosensitization for Borderline Resectable or Unresectable Pancreatic Cancer

por Arscott, William T., Nead, Kevin T., Bear, Adham, Venigalla, Sriram, Shabason, Jacob, Lukens, John N., Plastaras, John P., Wojcieszynski, Andrzej, Metz, James, O’Hara, Mark, Reiss, Kim A., Teitelbaum, Ursina, Loaiza-Bonilla, Arturo, Drebin, Jeffrey, Lee, Major K., Shroff, Stuti G., Ben-Josef, Edgar
Publicado 2021

2207: A Phase I dose escalation trial of nab-paclitaxel and fixed dose radiation in patients with unresectable or borderline resectable pancreatic cancer

por Ezra Shabason, Jacob, Chen, Jerry, Apisarnthanarax, Smith, Damjanov, Nevena, Giantonio, Bruce, Loaiza-Bonilla, Arturo, O’Dwyer, Peter, O’Hara, Mark, Reiss, Kim, Teitelbaum, Ursina, Wissel, Paul, Drebin, Jeffery, Vollmer, Charles, Kochman, Michael, Mick, Rosemarie, Vergara, Norge, Jhala, Nirag, Berman, Abigail, Dorsey, Jay, Evans, Sydney M., Kao, Gary, Lukens, John N., Plastaras, John P., Metz, James M., Ben-Josef, Edgar
Publicado 2018